| Cancers | |
| The IGF-II–Insulin Receptor Isoform-A Autocrine Signal in Cancer: Actionable Perspectives | |
| Pierluigi Scalia1  StephenJ. Williams1  Antonio Giordano1  | |
| [1] Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology, Biology Department, Temple University, Philadelphia, PA 19122, USA; | |
| 关键词: igf(i/ii/1r), insulin-like growth factor (1 or 2 or receptor); ira/ir-a; insulin receptor isoform a; igfbp; igf binding protein; itn; integrin; m6pr; mannose 6 phosphate receptor; tf; transferrin; vtn; vitronectin; hif; hypoxia-inducible factor; vhl; von hippel-lindau gene product; oct; off-context targeting; | |
| DOI : 10.3390/cancers12020366 | |
| 来源: DOAJ | |
【 摘 要 】
Insulin receptor overexpression is a common event in human cancer. Its overexpression is associated with a relative increase in the expression of its isoform A (IRA), a shorter variant lacking 11 aa in the extracellular domain, conferring high affinity for the binding of IGF-II along with added intracellular signaling specificity for this ligand. Since IGF-II is secreted by the vast majority of malignant solid cancers, where it establishes autocrine stimuli, the co-expression of IGF-II and IRA in cancer provides specific advantages such as apoptosis escape, growth, and proliferation to those cancers bearing such a co-expression pattern. However, little is known about the exact role of this autocrine ligand−receptor system in sustaining cancer malignant features such as angiogenesis, invasion, and metastasis. The recent finding that the overexpression of angiogenic receptor kinase EphB4 along with VEGF-A is tightly dependent on the IGF-II/IRA autocrine system independently of IGFIR provided new perspectives for all malignant IGF2omas (those aggressive solid cancers secreting IGF-II). The present review provides an updated view of the IGF system in cancer, focusing on the biology of the autocrine IGF-II/IRA ligand−receptor axis and supporting its underscored role as a malignant-switch checkpoint target.
【 授权许可】
Unknown